Key result
This editorial discusses findings that changes in osmotic strength modulate the slow outward delayed rectifier potassium current (IKs) in mammalian ventricular myocytes.
Answers are grounded in this paper and cite their sources.
Changes in osmotic strength significantly modulate IKs, which may impact repolarization and arrhythmogenesis during ischemia-reperfusion or dialysis.
This editorial refers to ‘Osmotic modulation of slowly activating IKs in guinea-pig ventricular myocytes’ by S. Missan et al., pp. 429–436, this issue. Repolarization of the mammalian heart action potential is a very important physiological variable. It sets action-potential duration and thus strongly modulates contractility and refractoriness in both the atria and the ventricles. Repolarization is initiated and controlled by the time- and voltage-dependent onset of a variety of different outward potassium (K+) currents, some of which are highly non-linear.1 One of these currents, the so-called slow outward delayed rectifier, or IKs, is expressed in the human ventricle. Its activation adds to the safety factor for repolarization (the so-called repolarization reserve) through its intrinsic time and voltage dependence. This is prominent following augmentation of IKs by sympathetic nerve stimulation.2 A paper in this issue from the McDonald laboratory3 confirms and extends what is known about the modulation of IKs in response to changes in osmotic strength of the external medium. A significant change in osmotic strength (±20–30%) may take place in the setting of ischaemia–reperfusion of the heart. This paper demonstrates relatively rapid (3–5 min to steady state) changes in IKs in single ventricular myocytes obtained from the hearts of adult guinea pigs in response to alterations in osmotic strength: reductions result in reversible increases in IKs and vice versa. These changes appear to be quite selective as judged by the reported lack of effect on a selected K+ current denoted HERG. The context for these findings and some aspects of their interpretation is aided by the quite detailed molecular information on the protein subunits which are responsible for the K+-selective channels that underlie IKs.4 The pore-forming α-subunit has been identified as KCNQ1 in the human heart, and a number of the important properties of this conductance are conferred by the stoichiometric and essential association of a β-subunit, denoted KCNE1, with KCNQ1.5,6 Similar K+ currents have been identified in a variety of mammalian tissues. These include a number of epithelial cells where they participate in secretory processes (see Jespersen etal.7 for review). In some Cl−-secreting epithelia, complexes formed by KCNQ1 and KCNEx β-subunits are localized in the basolateral membranes of the epithelial cells. This is the case with airway epithelia,8 small and large intestinal epithelia, and pancreatic acinar cells.9 Activation of KCNQ1 results in hyperpolarization of these cells, and this enhances the driving force for Cl− secretion on the apical surface. In the epithelia where KCNQ1 is localized on the apical side, its function is different. In the kidney proximal tubule, activation of KCNQ1 hyperpolarizes the apical membrane, which enhances the driving force for Na+ reabsorption.10 In the acid-secreting cells of the stomach, activation of IKs is a means to recycle the intracellular K+ that has accumulated due to the activity of the apical K+/H+ exchangers.11 In the marginal cells of the inner ear, IKs actively secretes K+ into the endolymph, which is an essential function for normal hearing.12,13 It is known that point mutations in either KCNQ1 or KCNE1 can result in marked changes in the macroscopic K+ current. Some of these mutations have been demonstrated to contribute to action-potential lengthening and to a form of the pro-arrhythmic (long Q-T) syndrome. In the case of the Jervell and Lange-Nielsen syndrome, one such mutation affects both heart rhythm and hearing, as a consequence of the dual but tissue-specific expression of the altered gene product KCNQ1.13 One way of beginning to understand the consequences of the osmolyte-induced changes in IKs reported by Missan et al.3 is to mathematically reconstruct the human ventricular action potential. This provides a useful visual comparison of the control action-potential waveform with the action potential computed after the experimentally observed osmolyte-induced changes in IKs have been introduced as input parameters. Figure 1 compares a control action potential (continuous line) with an action potential computed, following a 50% decrease in IKs (assumed hypertonic challenge, dashed line) and a two-fold increase in IKs (assumed hypotonic challenge, dotted line). As expected from the known role of IKs, the action-potential duration is changed somewhat. These moderate changes reflect the fact that under control (basal) conditions, the contribution of IKs to the net repolarizing outward current is quite small (10–15% of total). In the setting of enhanced activity (tone) of the sympathetic neuron (e.g. some type of heart failure), sympathetic tone is enhanced and an action of norepinephrine on β-receptors linked to IKs can enhance this current quite significantly. At a fixed heart rate, these changes could alter both excitability and refractoriness. The altered action-potential waveform could also be reflected as a change in the Q-T interval of the ECG, depending on the exact location of the change in osmotic strength, e.g. epi- vs. endocardium. Mathematical modelling of the effects of changes in osmotic strength on IKs and on the human ventricle action potential. (A) Human ventricle action potentials were computed according to the model by Fink et al.20 in control conditions (solid line) and after IKs conductance was modified to reproduce the experimental conditions of Missan et al.3: (i) a 50% decrease in IKs, representing hyperosmotic conditions (dashed line) and (ii) a two-fold increase in IKs, representing hyposmotic conditions (dotted line). (B) Simulated time courses of IKs currents and action-potential waveforms in the Fink et al.20 model of human ventricular myocytes. The input variable for maximal IKs conductance was adjusted to 50% of control (solid lines) to reproduce ∼1.35 hyperosmotic challenge (dashed lines), and changed to 2× the control value to reproduce ∼0.5 hyposmotic challenge (dotted lines), according to the experimental data from Missan et al.3 From the data presented and previous publications, it is clear that changes in osmotic strength can have significant effects on the magnitude of IKs. However, the underlying mechanism(s) remain to be resolved. For example, the results do not address whether the IKs response is due to stretch of the sarcolemma in the setting of hypotonic challenge or whether this K+ channel complex is otherwise sensitive to osmotic challenge.14 Moreover, the very slow time course of activation and deactivation of IKs raises an important principle that needs additional attention. Specifically, none of the voltage clamp protocols in this study actually drove the activation process of IKs to steady state. For this reason, the conclusion that there is no change in voltage dependence of activation is plausible but not certain. Further examination of this is important. Previous findings have demonstrated that large changes in the ionic osmolyte environment (external or internal) can result in altered screening of fixed charges within the membrane electrical field. This may significantly change the voltage dependence of channel-mediated Na+ and K+ fluxes.15,16 A related but different mechanism is based on possible modifications in the protein–lipid or protein–protein interactions due to altered electrostatic conditions.17,18 In this regard, data showing changes in cell volume or capacitance as a function of time would be instructive. In summary, it is now clear that IKs is a major target for osmotic stress.3,19 This is likely to have important consequences in the setting of ischaemia–reperfusion and perhaps also during cardioplegia applications or dialysis procedures. Conflict of interest: none declared. The W. Giles laboratory is funded by the Canadian Institute for Health Research and the Heart and Stroke Foundation of Alberta and the Northwest Territories. W.R.G. holds a Medical Scientist Award from the Alberta Innovates—Health Solutions Inc.
No takes yet. Share an insight, caveat, or question.
Banderali et al. (2011) reported an editorial. This editorial discusses findings that changes in osmotic strength modulate the slow outward delayed rectifier potassium current (IKs) in mammalian ventricular myocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: